1246672-06-9

Upstream product

• 358-23-6 trifluoromethylsulfonic anhydride 
• 1246672-05-8 8-benzyl-4-hydroxy-2-(methylthio)-7,8-dihydropyrido[2,3-d]pyrimidin-5(6H)-one 
• 1979-98-2 4,6-dihydroxy-2-methylmercaptopyrimidine 
• 1246672-04-7 ethyl ester of 4-(N-benzyl-N-(3-methoxy-3-oxopropyl)amino)-6-chloro-2-methyl-thio-pyrimidine-5-carboxylic acid 
• 959070-42-9 4,6-dichloro-2-(methylthio)pyrimidine-5-carboxylic acid ethyl ester 
• 6299-25-8 4,6-Dichloro-2-(methylthio)pyrimidine 

Downstream Products

• 1246669-48-6 6-benzyl-4-methylsulfanyl-2,6,7,8-tetrahydro-1,2,3,5,6-pentaazaacenaphthylene 
• 1246669-49-7 6-benzyl-4-methanesulfonyl-2,6,7,8-tetrahydro-1,2,3,5,6-pentaazaacenaphthylene 
• 1246669-50-0 6-benzyl-4-[4-(2-chloro-benzyl)-piperazin-1-yl]-2,6,7,8-tetrahydro-1,2,3,5,6-pentaazaacenaphthylene 

Relevant academic research and scientific papers

SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS

The present invention relates to substituted pyrazolo-pyrimidine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted pyrazolo-pyrimidine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds or pharmaceutical compositions to subjects in need thereof.